Health
Targeted treatments for EGFR-positive lung cancer can improve outcomes – Medical News Today
Targeted therapies are available for people with EGFR mutations, and they tend to be more effective. Learn more about the treatment…
EGFR mutations account for about 1015% of lung cancer cases in the United States. Biomarker testing allows oncologists to choose targeted treatments for these types of lung cancer.
Non-small cell lung cancer (NSCLC) accounts for about 85%
of lung cancer…
Continue Reading
-
Noosa News11 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General10 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
Noosa News11 hours agoBoy charged over E-Bike crash
-
General9 hours agoCrowe toasts talkback titan for platforming ‘voiceless’